Generic Name: Generic eriacta
What is Generic Eriacta?
Lamivudine at a dose of 100 mg once daily has also been shown to be effective for the treatment of adult patients with chronic HBV infection for details of clinical studies, see the prescribing information for Zeffix. However, for the treatment of HIV infection only a 300 mg daily dose of lamivudine in combination with other antiretroviral agents has been shown to be efficacious.
Lamivudine has not been specifically investigated in HIV patients co-infected with HBV. Once daily dosing 300 mg once a day : a clinical study has demonstrated the non inferiority between Epivir once a day and Epivir twice a day containing regimens.
Paediatric population: a randomised comparison of a regimen including once daily vs twice daily dosing of abacavir and lamivudine was undertaken within a randomised, multicentre, controlled study of HIV-infected, paediatric patients.
After 36 weeks on a regimen including twice daily abacavir and lamivudine, 669 eligible subjects were randomised to either continue twice daily dosing or switch to once daily abacavir and lamivudine for at least 96 weeks. This difference in suppression rates between tablets and solutions remained through Week 96 with once daily dosing.
More cases of resistance were detected among patients who had received lamivudine solution, in combination with other antiretroviral solutions, compared with those who received similar doses of tablet formulation. This is consistent with the lower rates of antiviral suppression observed in these patients.
The true extent of penetration or relationship with any clinical efficacy is unknown.
Get StartedMy MedicineSave your medicine, check interactions, sign up for FDA alerts, create family profiles and more. Get StartedDrug NewsMobile Drug Information AppDrug, supplement, and vitamin information on the go.
DownloadFeatured ContentImprove Your ConcentrationThese Foods and Drinks Can HelpAllergy AppFight allergies with daily forecasts, local alerts, and personalized tips. How to use EpivirRead the Patient Information Leaflet provided by your pharmacist before you start taking lamivudine and each time you get a refill. What conditions does Epivir treat. Side Effects See also Warning section.
In the US -Call your doctor for medical advice about side effects.
How should I take Generic Eriacta?
You are not eligible to use this card if your sole or primary prescription drug benefit is through a government-funded plan see complete eligibility requirements for additional information. Click Here For DetailsThis Free drug coupon has No Membership Fees and provides access to wholesale Epivir prices.
Over 68,000 participating pharmacies accept this Reusable drug coupon. Note: prescription is required for savings. No significant drug interactions. Do not take Epivir with Atripla, Combivir, Complera, Descovy, Emtriva, Epivir-HBV, Epzicom, Genvoya, Hepsera, Odefsey, Stribild, Triumeq, Trizivir, or Truvada, since they contain Epivir or medication from the same drug class.
Epivir may be used with hepatitis C drugs such as Daklinza, Epclusa, Harvoni, Olysio, Sovaldi, Viekira Pak, or Zepatier, depending on the other components in the HIV regimen. One benefit of Epivir is that the drug resistance the virus develops against the drug makes the virus less able to reproduce.
What should I avoid while taking Generic Eriacta?
Code Definition PA Prior Authorization Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription. QL Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST Step Therapy Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription. OR Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription. Share cases and questions with Physicians on Medscape consult.
Generic Eriacta side effects
Safety and efficacy of lamivudine have not been established for treatment of chronic hepatitis B in patients co-infected with HIV-1 and HBV. If treatment with EPIVIR-HBV is prescribed for chronic hepatitis B for a patient with unrecognized or untreated HIV-1 infection, rapid emergence of HIV-1 resistance is likely to result because of the subtherapeutic dose and the inappropriateness of monotherapy HIV-1 treatment.
If a decision is made to administer lamivudine to patients co-infected with HIV-1 and HBV, EPIVIR tablets, EPIVIR oral solution, or another product containing the higher dose of lamivudine should be used as part of an appropriate combination regimen. Safety and efficacy of lamivudine have not been established for treatment of chronic hepatitis B in subjects dually infected with HIV-1 and HBV see full prescribing information for EPIVIR-HBV.
Emergence of hepatitis B virus variants associated with resistance to lamivudine has also been reported in HIV-1-infected subjects who have received lamivudine-containing antiretroviral regimens in the presence of concurrent infection with hepatitis B virus.
Common Generic Eriacta ide effects may include:
Epivir is available as generic lamivudine, which should be as effective and well tolerated as the brand name drug Epivir.
Legal Notices Privacy Statement Contact UsThis website is funded and developed by GSK.
If you have hepatitis B and stop taking lamivudine, your health care provider should carefully monitor your liver function for several months.
Update your browser to view this website correctly.
QL Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered. ST Step Therapy Drugs that have step therapy associated with each prescription.
This restriction typically requires that certain criteria be met prior to approval for the prescription. OR Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Where can I get more information?
As in the adult controlled trials, most lamivudine-treated subjects had decreases in HBV DNA below the assay limit early in treatment, but about one third of subjects with this initial response had reappearance of assay-detectable HBV DNA during treatment.
The cause and long-term effects of these changes are unknown.